Emergency coronary artery bypass grafting (CABG) after failed coronary artery intervention--caution regarding the combined use of aspirin, ticlopidine and abciximab.
Alvarez
J M
JM
Harper
R W
RW
Peverill
R E
RE
D000077284:Abciximab; D000328:Adult; D000787:Angina Pectoris / Q000628:therapy; D015906:Angioplasty, Balloon, Coronary; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D001241:Aspirin / Q000009:adverse effects*; D016063:Blood Loss, Surgical; D001026:Coronary Artery Bypass; D003328:Coronary Thrombosis / Q000209:etiology*; D004359:Drug Therapy, Combination; D004630:Emergencies; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000009:adverse effects*; D007262:Infusions, Intravenous; D007431:Intraoperative Complications; D008297:Male; D009203:Myocardial Infarction / Q000209:etiology / Q000628:therapy*; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects*; D011183:Postoperative Complications; D015607:Stents / Q000009:adverse effects; D013988:Ticlopidine / Q000009:adverse effects*
D000911:Antibodies, Monoclonal; D007140:Immunoglobulin Fab Fragments; D010975:Platelet Aggregation Inhibitors; D013988:Ticlopidine; D001241:Aspirin; D000077284:Abciximab